Advancing Precision Medicine Globally: From Gene Therapy to HLA CDx Commercialization
Time: 5:00 pm
day: Day One
Details:
- Lessons from the first cell based CDx FDA approval in gene therapy
- Understand the dynamics of 3-way and 2-way partnerships models between pharma, IVD companies, and Labcorp with real world examples
- Strategic Considerations for Global Commercialization: from early development to trials, regulatory oversight, and post-commercialization support
